KayoThera has taken part in the NYU Stern Business School Endless Frontier Labs accelerator program since October 2020 to refine the business plan and expand the company trajectory and growth initiatives. This accelerator was exceptionally valuable to the development and expansion of Kayothera as we pursue our goal to cure incurable cancers through the development of a novel immunotherapy for solid tumors. We are excited to announce our graduation from this program this upcoming May 6th, 2021. Attendance is open to the public for our afternoon presentation.